Chung C T, Sagerman R H, Ryoo M C, King G A, Yu W S, Dalal P S, Emmanuel I G
Radiology. 1980 Sep;136(3):753-6. doi: 10.1148/radiology.136.3.6773105.
Thirty-eight patients with residual or recurrent primary thyroid cancers which did not take up 1-131 were treated with external beam irradiation. Excluding 5 patients with malignant lymphoma, there were 23 patients with local disease and 10 with distant metastases. Doses ranged from 3,500 to 7,000 rads (35-70 Gy) among the 23 with local disease; local tumor control was achieved in 8. Six are alive and well 2-11 years later. External beam irradiation should be considered in locally advanced, incompletely resected, recurrent and metastatic thyroid malignancies of all histological types without 1-131 uptake. Reviewed are the age and sex distribution, histology, stage, extent of surgery, and dose and radiotherapy technique as they affect survival and patterns of failure.
38例残留或复发性原发性甲状腺癌患者,其病灶不摄取1-131,接受了外照射治疗。排除5例恶性淋巴瘤患者后,有23例为局部病变,10例有远处转移。23例局部病变患者的照射剂量为3500至7000拉德(35-70戈瑞);8例实现了局部肿瘤控制。6例在2至11年后仍存活且状况良好。对于所有组织学类型、不摄取1-131的局部晚期、未完全切除、复发和转移性甲状腺恶性肿瘤,应考虑外照射治疗。本文回顾了年龄和性别分布、组织学、分期、手术范围以及影响生存和失败模式的剂量和放疗技术。